Colgate-Palmolive (CL) Beats Expectations as Analysts Raise Price Targets

Colgate-Palmolive Company (NYSE:CL) is included among the 11 Best Rising Dividend Stocks to Buy Right Now.

Colgate-Palmolive (CL) Beats Expectations as Analysts Raise Price Targets

On May 5, Barclays raised its price recommendation on Colgate-Palmolive Company (NYSE:CL) to $80 from $79. It reiterated an Equal Weight rating on the shares. The firm said it believes the company is focusing on achieving a better balance between pricing and volume growth in 2026.

A few days earlier, on May 2, Goldman Sachs raised its price goal on Colgate-Palmolive to $100 from $98. It maintained a Buy rating on the stock. The firm pointed to the company’s stronger-than-expected Q1 results, with both revenue and earnings coming in ahead of expectations. According to the analyst, organic sales growth was higher than anticipated, while broad-based strength across the business also supported slightly better-than-expected gross margins. Goldman Sachs added that EBIT margins remained in line with expectations even as advertising spending increased 10% during the quarter.

Colgate-Palmolive Company (NYSE:CL) focuses on oral care, personal care, home care, and pet nutrition products.

While we acknowledge the risk and potential of CL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CL and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 12 Best Micro-Cap Dividend Stocks To Buy Now and 10 Best Stocks to Buy Now for a $1 Million Portfolio

Disclosure: None. Follow Insider Monkey on Google News.